(Washington, D.C.: May 9, 2016) – Consumers Union, the policy and advocacy division of Consumer Reports, submits these comments in support of the proposed rule regarding the Medicare Part B Drug Payment Model Program. We are deeply concerned about the affordability of drugs for consumers and the growth of health system costs, both due, in part, to rising drug costs. It is imperative that we get these costs under control; they threaten our healthcare system, as well as household, federal and state budgets.
Comments regarding 1670-P Proposed Rulemaking for CMS Part B Drug Program
May 9, 2016